Drug Topics June 24, 2025
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.
As health plans move away from traditional pharmacy benefit manager (PBM) pricing models, experts believe more transparency will be introduced within the benefits market. With cost-plus models and PBM unbundling highlighted in the 2025 Trends in Drug Benefit Design Report, authors of the report are seeing an evolution in the way drug benefits are facilitated.
“Plans today are really seeking additional flexibility in administering their plan,” said Scott Halperin, PharmD, senior pharmacy benefit clinical consultant of employer groups at the Pharmaceutical Strategies Group (PSG). “Perhaps they want to drive toward an in-house pharmacy, like we...
Today's Sponsors
Today's Sponsor